Abstract P3-02-05: Assessment of repeatability and uptake quantification of 68GaNOTA-anti-HER2 sdAb PET/CT in patients with locally advanced or metastatic breast cancer
Odrade Gondry(Vrije Universiteit Brussel), Marleen Keyaerts(Vrije Universiteit Brussel), Sheeno Thyparambil(Microprobes (United States)), Marian Vanhoeij(Universitair Ziekenhuis Brussel), Katrien Glorieus(Universitair Ziekenhuis Brussel), Sophie Bourgeois(Universitair Ziekenhuis Brussel), Catarina Xavier(Vrije Universiteit Brussel), Frederik Vandenbroucke(Universitair Ziekenhuis Brussel), Ine Luyten(Universitair Ziekenhuis Brussel), Sandrine Aspeslagh(Universitair Ziekenhuis Brussel), Omar Al Dabssi(Universitair Ziekenhuis Brussel), Nick Devoogdt(Vrije Universiteit Brussel), Julie Cousaert(Universitair Ziekenhuis Brussel), Vicky Caveliers(Vrije Universiteit Brussel), Jacques De Grève(Vrije Universiteit Brussel), Wim Waelput(Vrije Universiteit Brussel), Hendrik Everaert(Universitair Ziekenhuis Brussel), Tony Lahoutte(Citrix (Switzerland)), Ilse Vaneycken(Universitair Ziekenhuis Brussel), Christel Fontaine(Universitair Ziekenhuis Brussel), Sofie Joris(Universitair Ziekenhuis Brussel), Laurens Raes(Universitair Ziekenhuis Brussel), Guy Verfaillie(Universitair Ziekenhuis Brussel)
Cited by 0
Related Papers
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
|PLoS ONE|2013|267
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
|BMC Medicine|2012|131
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
|Oncotarget|2016|100
Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
|PLoS ONE|2013|51
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
|Biological Procedures Online|2010|46